Skip to content
Penicillin g benzathine
Bicillin (penicillin g benzathine) is a small molecule pharmaceutical. Penicillin g benzathine was first approved as Permapen on 1982-01-01. It is used to treat actinomycosis, anthrax, bacterial infections, bacterial skin diseases, and botulism amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
musculoskeletal diseasesD009140
respiratory tract diseasesD012140
nervous system diseasesD009422
urogenital diseasesD000091642
cardiovascular diseasesD002318
skin and connective tissue diseasesD017437
animal diseasesD000820
signs and symptoms pathological conditionsD013568
chemically-induced disordersD064419
Trade Name
FDA
EMA
Bicillin l-a (discontinued: Bicillin, Permapen)
Combinations
Bicillin c-r
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Penicillin g benzathine
Tradename
Company
Number
Date
Products
BICILLIN L-AKing PharmaceuticalsN-050141 RX1982-01-01
1 products, RLD, RS
Show 5 discontinued
Penicillin g benzathine
+
Penicillin g procaine
Tradename
Company
Number
Date
Products
BICILLIN C-RKing PharmaceuticalsN-050138 RX1982-01-01
1 products, RLD, RS
BICILLIN C-R 900/300King PharmaceuticalsN-050138 RX1982-01-01
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
bicillin l-aNew Drug Application2022-08-25
bicillin l-aNew Drug Application2022-08-25
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
actinomycosisEFO_0007128D000196A42
anthrax—D000881A22
bacterial infections—D001424A49
bacterial skin diseases—D017192—
botulismEFO_0005542D001906A05.1
diphtheriaEFO_0005549D004165A36
empyemaEFO_0003097D004653—
endocarditisEFO_0000465D004696I33
erysipelothrix infectionsEFO_1000927D004889—
escherichia coli infectionsEFO_1001318D004927B96.20
Show 14 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01C: Beta-lactam antibacterials, penicillins
— J01CE: Beta-lactamase sensitive penicillins
— J01CE08: Benzathine benzylpenicillin
HCPCS
Code
Description
J0558
Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
J0561
Injection, penicillin g benzathine, 100,000 units
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePENICILLIN G BENZATHINE
INNbenzathine benzylpenicillin
Description
Benzathine benzylpenicillin, also known as benzathine penicillin G, is an antibiotic medication useful for the treatment of a number of bacterial infections. Specifically it is used to treat strep throat, diphtheria, syphilis, and yaws. It is also used to prevent rheumatic fever. It is given by injection into a muscle.
Classification
Small molecule
Drug classpenicillins
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.O.O.O.O.c1ccc(CNCCNCc2ccccc2)cc1
Identifiers
PDB—
CAS-ID1538-09-6
RxCUI—
ChEMBL IDCHEMBL3989515
ChEBI ID—
PubChem CID15232
DrugBankDB09323
UNII IDSSZ1S4I0US (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,348 documents
View more details
Safety
Black-box Warning
Black-box warning for: Bicillin l-a, Bicillin l-a
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
7 adverse events reported
View more details